scispace - formally typeset
R

Raffaella Vergura

Researcher at University of Ferrara

Publications -  9
Citations -  477

Raffaella Vergura is an academic researcher from University of Ferrara. The author has contributed to research in topics: Receptor & Agonist. The author has an hindex of 7, co-authored 9 publications receiving 458 citations.

Papers
More filters
Journal ArticleDOI

Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice

TL;DR: The effects of in vivo supraspinal NPS in mice are evaluated and it is shown that in vivo NPS produces a unique behavioural profile by increasing wakefulness and exerting anxiolytic‐like effects.
Journal ArticleDOI

Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation.

TL;DR: This study identified the amino acid residues of this peptide most important for receptor activation as Thr8-Gly9-Met10, suggesting that the C-terminal region of the peptide maintains importance for in vivo activity.
Journal ArticleDOI

Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist.

TL;DR: The present findings demonstrate that UFP-512 behaves as a highly potent and selective agonist at Dop receptors and corroborate the proposal that the selective activation of DOP receptors elicits robust anxiolytic- and antidepressant-like effects in rodents.
Journal ArticleDOI

Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation.

TL;DR: It is demonstrated that N/OFQ stimulates human monocyte chemotaxis via NOP receptor activation through the order of potency of agonists and the antagonist selectivity.
Journal ArticleDOI

In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4–11) (UFP-803)

TL;DR: UFP‐803 is a potent UT receptor ligand which displays competitive/noncompetitive antagonist behavior depending on the assay, and is less potent than urantide, which displayed reduced residual agonist activity and as such may be a useful pharmacological tool.